Article Details

Medtronic's HeartWare HVAD ending brings questions about $1.1B acquisition

Retrieved on: 2021-06-08 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

Medtronic's HeartWare HVAD ending brings questions about $1.1B acquisition. View article details on hiswai:

Excerpt

The company advised against elective explant due to health risks. ... Mike Argentieri, ECRI's vice president of technology and safety, said physicians ...

Article found on: www.medtechdive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up